Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Cystadrops

Generic name: Cysteamine hydrochloride

FDA application holder: Recordati Rare

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Cystadrops?
Cystadrops is a brand name of Cysteamine hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Cystadrops product in 1 strength and form.
Who makes Cystadrops?
Recordati Rare holds the FDA application for Cystadrops (NDA211302, approved August 19, 2020).
Is there a generic or store brand of Cystadrops?
Other products of Cysteamine hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Cystadrops product.
Has Cystadrops been recalled?
No recall linked to Cystadrops products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Cystadrops is

Each Cystadrops product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Cysteamine hydrochloride · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
cysteamine hydrochloride 3.5 mg/mL
solution (ophthalmic)
Cystadrops None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cysteamine hydrochloride →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Cystadrops products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA211302Recordati RareAugust 19, 20201

Companies that list Cystadrops

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cystadrops products.

Recalls

No recall linked to Cystadrops products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers